Although systemic lupus erythematosus is the prototype multisystem disease, many other inflammatory diseases are also promiscuous, with symptoms manifesting in many organs. Now, new data emphasize the extra-articular involvement in spondyloarthritis, predominantly affecting the eye; however, the factors that account for the observed organ involvement remain unknown.
Canouï-Poitrine et al. 1 recently conducted a survey of French rheumatologists to iden tify extra-articular manifestations in patients with spondyloarthritis (SpA). Dubbed EXTRA and reported in Arthritis Care & Research, 1 their survey identified 902 patients, 71% with ankylosing spondylitis (AS) and the rest with psoriatic arthritis or another form of SpA. They concluded that 32.2% of those in the survey had a history of uveitis, 1 a term used to describe intraocular inflammation, which is a topic that often lies outside of general rheumatology training. Indeed, uveitis was 44% more prevalent than psoriasis in this cohort, almost four times more frequently observed than clinically identified inflammatory bowel disease, and substantially more common than heart, lung, or genitourinary associations. 1 The findings of Canouï-Poitrine and colleagues strongly agree with the results of a 2008 meta-analysis, which demonstrated a 32.7% prevalence of uveitis among patients with SpA. 2 These data raise a question: why do uveal disease and sacroiliitis, spondylitis, enthesitis or other articular manifestations of SpA coexist?
SpA is not unique in affecting both joints and the uveal tract. For example, the sub set of juvenile idiopathic arthritis that is charac terized by typically pauciarticular dis ease, female predominance, and antinuclear antibody positivity is also often asso ciated with uveitis. Whipple's disease, which results from Tropheryma whipplei infection, resembles AS, ulcerative colitis, reactive arthritis and Crohn's disease by having a predilection for bowel, joint and eye involvement. Lyme disease is another infectious disease with the potential to cause uveitis and arthritis. Furthermore, Behçet disease, sarcoidosis, relapsing polychondritis, Kawasaki disease, other forms of vasculitis, and systemic lupus erythematosus also belong to the differential diagnosis of uveitis and arthritis. In addition, Blau syndrome, an auto somal dominant disease caused by a mutation in NOD2 (also known as CARD15), a gene that has a role in innate immunity, is charac terized Figure 1 | The skin, eyes, spine, peripheral joints, tendons and bowel can be simultaneously inflamed in spondyloarthritis. Factors that could contribute to this multiorgan manifestation include genes such as HLA-B27 and IL23R, environmental factors such as bacteria, shared antigens such as aggrecan, and common leukocyte migration factors such as adhesion molecules or chemotactic stimuli. Factors that are as yet to be identified undoubtedly contribute to this amalgamation of inflammation. 4 Although the polymorphisms in NOD2 associated with Crohn's disease are distinct from the mutations responsible for Blau syndrome, 4 these observations clearly demonstrate that the site where the gene is expressed is not sufficient to explain the predominant organ involvement in these conditions.
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Presumably more than one mechanism accounts for the link between eye and joint inflammation (Figure 1) . Genetic factors such as HLA-B27 or polymorphisms in the gene encoding the IL-23 receptor (IL23R) are common both to patients who develop AS 5 and those who develop acute anterior uveitis (T. M. Martin, unpublished work). Presumably shared genetic factors contribute to coincidental eye, joint, bowel and skin disease, but this does not preclude identification of genetic factors that are unique for specific organs. For example, data from studies in mice suggest that genes that predispose to peripheral arthritis can be distinguish ed from the genes that promote axial disease. 6 The existence of an antigen expressed in all the affected, but not the unaffected organs would provide a simple explanation for the organ involvement seen in SpA. Indeed, eyes and joints both con tain potential shared antigens such as aggre can, type II col lagen and hyaluronic acid; however, evidence suggesting that HLA-B27-associated dis eases represent an autoimmune response against one of these antigens or any other antigen is limited. Furthermore, these an tigens are not restricted to the eye and joint.
Environmental factors such as bacil lary dysenteries are strongly implicated in some forms of SpA, such as reactive arthritis. Com ponents of bacterial cells have been detected in the inflamed synovium, 7 and might activate the innate immune system and enable ingress of leukocytes, including T cells, into the joint tissue. Whether a similar phenomenon occurs in the uvea remains unknown. Nevertheless, adhesion molecules do vary between different tissue beds, 8 and these 'addresses' could conceivably be shared between the uvea and the synovium, directing inflammatory cells to both locations.
Animal models could help clarify the mechanism underlying the dual vulnerability of the eyes and joints in SpA. However, we are aware of only two such models des cribing this combination of organ involve ment, perhaps because the major ity of investigators do not meticulously examine the eye for evidence of inflammatory disease. Adjuvant arthritis can be induced in specific strains of rats by an injection of Freund's adjuvant, which con sists of killed myco bacteria in mineral oil. The affected rodents develop many fea tures characteris tic of SpA including spondy litis, new bone formation and even non gonococcal urethri tis; 9 uveitis is also well described in this model. 9 In adjuvant arthritis, granulomas can be detected in the uveal tract and the inflammation is often bilateral. 9 These features differ from uveitis associated with AS, as eye inflam mation is typically unilateral and is clinically described as nongranulomatous in this disease.
We and our colleagues have also detected uveitis in an established model of arthritis, in which BALB/c mice are immunized with aggrecan. 10 Aggrecan is the main proteoglycan in entheses, the tendinous insertions in bone, which are a major target for inflammation in SpA. This model of eye dis ease is more consistent in transgenic mice whose T-cell receptors specifically recog nize the G1 epitope of aggrecan. 10 Aggrecan is detectable in synovial and peripheral joints along with the uveal tract, but expression of this proteoglycan is not limited to these sites. Moreover, although the uvea and synovium are both affected in this model, the cytokine dependence of inflammation in each of these organs is substantially different; the absence of IFN-γ ameliorates joint dis ease whilst markedly exacerbating eye dis ease. 10 Nevertheless, this model could be useful in determining whether T cells that migrate into the eye use the same adhesion molecules as those that infiltrate the joints, and will enable further investigation into the link between joint and uveal inflammation.
Ironically, in a clinical sense, uveitis and spondylitis are opposites: in patients with AS, uveitis typically has a sudden onset, affects only one eye at a time and resolves completely between episodes; sacroili itis has an insidious onset, is bilateral and persists continuously. Thus, these features of SpA make an odd couple. Unraveling the mys tery of their association could help us better understand the pathoetiology of SpA.
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